Hologic (HOLX) Ratings Affirmed by S&P Following Credit Facility Refinancing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Hologic (HOLX) PT Boosted to $40 at Canaccord Genuity Following Meetings
June 1, 2015 8:43 AM EDTCanaccord Genuity analyst Mark Massaro reiterated a Buy rating and boosted his price target on Hologic (NASDAQ: HOLX) to $40.00 (from $37.00) after hosting investor meetings with Hologic CEO Steve MacMillan and CFO Bob McMahon.
Massaro commented, "Following a really strong quarter, we... More
